HIFU vs Uterine Artery Embolisation: How Do the Options Differ?

HIFU uses focused ultrasound energy to heat selected fibroid tissue from outside the body. Uterine artery embolisation (UAE), also called uterine artery embolization, uses a catheter to deliver particles that reduce the fibroids’ blood supply. Both aim to relieve symptoms while keeping the uterus, but neither is right for everyone or guarantees future pregnancy. The useful question is not which treatment is universally better, but which fits your symptoms, imaging, reproductive plans and willingness to accept further treatment. [1–4]

Two different ways of treating fibroids

With HIFU, imaging guides ultrasound energy towards a target. Ultrasound-guided HIFU uses ultrasound imaging during treatment; MRI-guided focused ultrasound, often called MRgFUS, uses MRI imaging and temperature mapping. They share a treatment principle, but their devices, monitoring and evidence are not interchangeable. [1,2]

With UAE, an interventional radiologist passes a catheter into the arteries supplying the uterus and injects embolic particles. This reduces blood flow to the fibroids rather than heating individual targets through the skin. It is less invasive than an operation to remove the uterus, but it is still an invasive vascular procedure. Neither UAE nor HIFU is surgical removal of a fibroid. [1–3]

What makes one option worth discussing?

The assessment should start with the symptoms you want to improve and whether fibroids explain them. Bleeding, pressure and pain may need different evaluation; an image alone cannot determine the best treatment. Other options include medication, myomectomy, hysterectomy or monitoring when appropriate. [1–3]

For HIFU, the clinician needs to assess whether the planned target can be reached safely through the tissues between the skin and the fibroid. For UAE, the review includes whether embolisation is appropriate for the uterine and vascular findings. Ask how the proposed approach addresses your particular fibroids, rather than relying on a rule based only on diameter or number. Our related articles on multiple fibroids and imaging review for large fibroids explain the imaging questions in more detail. [1–3]

Pain control, risks and follow-up

An incision-free procedure is not necessarily painless or risk-free. NICE describes intravenous sedation as an option for ultrasound-guided HIFU and as usual for MR-guided treatment. Its UAE description uses local anaesthesia with conscious sedation. These are general descriptions, not a statement of BARUN’s protocols or a promise about your anaesthesia. Ask the treating team who will provide pain control and monitoring. [1–3]

HIFU risks include skin burns and injury to nearby structures; risks depend on the technique and treatment plan. UAE risks include pain and post-embolisation symptoms, infection, arterial or access-site injury, and effects on ovarian function. Serious complications can require further treatment. This is not an exhaustive risk list, and the frequency of a complication in one study should not be treated as your personal risk. [1–3]

For either procedure, agree in advance how symptoms and imaging will be reassessed, who to contact if problems arise, and what would prompt another intervention. Improvement in a scan is not the same outcome as relief of bleeding or pressure. No fixed recovery, work-return or flying timetable is promised here. [1–3]

What does the direct comparison actually show?

The FIRSTT study compared UAE with MRI-guided focused ultrasound, not ultrasound-guided HIFU. Its main analysis combined a randomised group with a non-randomised observational group. Among 83 treated participants, further fibroid procedures occurred in 13 of 43 MRgFUS participants and 5 of 40 UAE participants during study follow-up. The primary outcome concerned reintervention within 36 months, with planned follow-up of 24–36 months and incomplete follow-up for some participants. These are not complete three-year recurrence rates. [4]

Both groups reported improvement, and UAE had more favourable symptom and quality-of-life results in this study. However, the study was small, included treatment-choice participants and used an older MRgFUS platform. Its findings do not establish that UAE is better than every form of HIFU, nor predict what will happen to an individual patient. [4]

NICE also distinguishes the techniques. Its current published guidance supports UAE and MR-guided focused ultrasound under normal clinical-governance arrangements, while ultrasound-guided HIFU requires special governance, consent and audit or research arrangements because efficacy evidence is limited in quality. These UK recommendations are not a description of Korean regulatory requirements. The guidance documents were last reviewed in 2010, 2011 and 2019 respectively; their current availability does not mean a new 2026 evidence review has taken place. [1–3]

If future pregnancy matters

Keeping the uterus does not prove that a treatment preserves fertility. NICE describes uncertainty about fertility and pregnancy after these procedures. FIRSTT excluded people actively trying to conceive and cannot decide which option gives a better chance of a baby. Discuss reproductive plans before choosing treatment, including whether a different approach such as myomectomy merits specialist discussion. Do not use a general article to choose a waiting interval before pregnancy. [1–4]

Care at BARUN

BARUN uses ultrasound-guided HIFU (US-guided HIFU). When UAE is being considered, care is coordinated with a radiology specialist. This does not mean that UAE is performed at BARUN or that either procedure is suitable for every patient.

Questions for your consultation

• Which exact HIFU technique or UAE procedure is being proposed, and why does it fit my imaging?
• What symptom improvement is realistic, and how will we measure it?
• Which complications matter most in my case, and how are they managed?
• What are the alternatives if the first procedure does not help enough?
• If pregnancy matters to me, what remains uncertain and who should advise me?
• Which services are provided here, which require referral, and who will arrange follow-up?

Frequently asked questions

Is UAE a type of HIFU?

No. UAE changes blood supply through an arterial catheter; HIFU delivers focused ultrasound energy from outside the body. Similar goals do not make the procedures equivalent. [1–3]

Does needing another treatment mean the fibroid has grown back?

Not necessarily. Further treatment may reflect persistent symptoms or an incomplete initial response. A reintervention endpoint records another procedure, not simply a new or enlarged fibroid on imaging. [1–4]

Can I compare success percentages from different clinics?

Only if the outcomes, patients, technique and follow-up are comparable. Ask whether “success” means symptom relief, an imaging change or no further procedure, and how many participants were still followed. FIRSTT’s figures should not be repackaged as a clinic-specific success rate. [4]

References

1. NICE. Ultrasound-guided high-intensity transcutaneous focused ultrasound for symptomatic uterine fibroids. HTG523. Last reviewed 24 July 2019. Recommendations, procedure, safety considerations.
2. NICE. Magnetic resonance image-guided transcutaneous focused ultrasound for uterine fibroids. HTG277. Last reviewed 23 November 2011. Recommendations, procedure and safety.
3. NICE. Uterine artery embolisation for fibroids. HTG240. Last reviewed 24 November 2010. Recommendations, procedure and safety.
4. Laughlin-Tommaso SK, et al. FIRSTT comparative outcomes study. American Journal of Obstetrics and Gynecology. 2019;220:174.e1–174.e13. doi:10.1016/j.ajog.2018.10.032. Full text.

AI-assisted content. Reviewed and approved by Dr Ki Hyon Kil on 27 October 2026. This is general education, not a diagnosis or personal treatment recommendation.